{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:03:58Z","timestamp":1784991838852,"version":"3.55.0"},"reference-count":26,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2022,5,30]]},"DOI":"10.1536\/ihj.21-801","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T22:10:34Z","timestamp":1653948634000},"page":"531-540","source":"Crossref","is-referenced-by-count":14,"title":["Native Myocardial T1 Value in Predicting 1-Year Outcomes in Patients with Nonischemic Dilated Cardiomyopathy Experiencing Recent Heart Failure"],"prefix":"10.1536","volume":"63","author":[{"given":"Toshiro","family":"Kitagawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuminari","family":"Tatsugami","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Hiroshima University Graduate School of Biomedical and Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Yokomachi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hiroshima University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hiroshima University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Awai","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Hiroshima University Graduate School of Biomedical and Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. McCrohon JA, Moon JC, Prasad SK, <i>et al<\/i>. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003; 108: 54-9.","DOI":"10.1161\/01.CIR.0000078641.19365.4C"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005; 26: 1461-74.","DOI":"10.1093\/eurheartj\/ehi258"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Assomull RG, Prasad SK, Lyne J, <i>et al<\/i>. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48: 1977-85.","DOI":"10.1016\/j.jacc.2006.07.049"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wu KC, Weiss RG, Thiemann DR, <i>et al<\/i>. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008; 51: 2414-21.","DOI":"10.1016\/j.jacc.2008.03.018"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Gulati A, Jabbour A, Ismail TF, <i>et al<\/i>. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013; 309: 896-908.","DOI":"10.1001\/jama.2013.1363"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Iles L, Pfluger H, Phrommintikul A, <i>et al<\/i>. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008; 52: 1574-80.","DOI":"10.1016\/j.jacc.2008.06.049"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Puntmann VO, Voigt T, Chen Z, <i>et al<\/i>. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 2013; 6: 475-84.","DOI":"10.1016\/j.jcmg.2012.08.019"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sibley CT, Noureldin RA, Gai N, <i>et al<\/i>. Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology 2012; 265: 724-32.","DOI":"10.1148\/radiol.12112721"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M, Francis JM, Karamitsos TD, Prendergast BD, Robson MD, Neubauer S, Moon JC, Myerson SG. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart 2013; 99: 932-7.","DOI":"10.1136\/heartjnl-2012-303052"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nakamori S, Dohi K, Ishida M, <i>et al<\/i>. Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc Imaging 2018; 11: 48-59.","DOI":"10.1016\/j.jcmg.2017.04.006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22: 6A-13A.","DOI":"10.1016\/0735-1097(93)90455-A"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Maron BJ, Towbin JA, Thiene G, <i>et al<\/i>. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807-16.","DOI":"10.1161\/CIRCULATIONAHA.106.174287"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lang RM, Bierig M, Devereux RB, <i>et al<\/i>. Recommendations for chamber quantification: a report from the American Society of Echocardiography&apos;s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-63.","DOI":"10.1016\/j.echo.2005.10.005"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kubanek M, Sramko M, Maluskova J, <i>et al<\/i>. Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy. J Am Coll Cardiol 2013; 61: 54-63.","DOI":"10.1016\/j.jacc.2012.07.072"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004; 52: 141-6.","DOI":"10.1002\/mrm.20110"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Messroghli DR, Walters K, Plein S, <i>et al<\/i>. Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med 2007; 58: 34-40.","DOI":"10.1002\/mrm.21272"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Piechnik SK, Ferreira VM, Dall&apos;Armellina E, <i>et al<\/i>. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010; 12: 69.","DOI":"10.1186\/1532-429X-12-69"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hamdy A, Kitagawa K, Ishida M, Sakuma H. Native myocardial T1 mapping, Are we there yet? Int Heart J 2016; 57: 400-7.","DOI":"10.1536\/ihj.16-169"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Poindron V, Chatelus E, Canuet M, <i>et al<\/i>. T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients. Semin Arthritis Rheum 2020; 50: 128-34.","DOI":"10.1016\/j.semarthrit.2019.06.013"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Oda S, Utsunomiya D, Morita K, <i>et al<\/i>. Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy. Eur Radiol 2017; 27: 4631-8.","DOI":"10.1007\/s00330-017-4845-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. aus dem, Siepen F, Buss SJ, Messroghli D, <i>et al<\/i>. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 2015; 16: 210-6.","DOI":"10.1093\/ehjci\/jeu183"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Merlo M, Pyxaras SA, Pinamonti B, Barbati G, Di Lenarda A, Sinagra G. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol 2011; 57: 1468-76.","DOI":"10.1016\/j.jacc.2010.11.030"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Xu Y, Li W, Wan K, <i>et al<\/i>. Myocardial tissue reverse remodeling after guideline-directed medical therapy in idiopathic dilated cardiomyopathy. Circ Heart Fail 2021; 14: e007944.","DOI":"10.1161\/CIRCHEARTFAILURE.120.007944"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Puntmann VO, Carr-White G, Jabbour A, <i>et al<\/i>. T1-mapping and outcome in nonischemic cardiomyopathy: All-cause mortality and heart failure. JACC Cardiovasc Imaging 2016; 9: 40-50.","DOI":"10.1016\/j.jcmg.2015.12.001"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tsuchihashi M, Tsutsui H, Kodama K, Kasagi F, Takeshita A. Clinical characteristics and prognosis of hospitalized patients with congestive heart failure--a study in Fukuoka, Japan. Jpn Circ J 2000; 64: 953-9.","DOI":"10.1253\/jcj.64.953"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Li S, Zhou D, Sirajuddin A, <i>et al<\/i>. T1 mapping and extracellular volume fraction in dilated cardiomyopathy: A prognosis study. JACC Cardiovasc Imaging 2021 in press.","DOI":"10.1016\/j.jcmg.2021.07.023"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/63\/3\/63_21-801\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T04:21:10Z","timestamp":1654316470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/63\/3\/63_21-801\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.21-801","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]},"article-number":"21-801"}}